Viewing Study NCT00159757


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-26 @ 3:29 PM
Study NCT ID: NCT00159757
Status: TERMINATED
Last Update Posted: 2021-02-21
First Post: 2005-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords: